The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $245.63 in the prior trading day, Inspire Medical Systems Inc (NYSE: INSP) closed at $163.41, down -33.47%. In other words, the price has decreased by -$33.47 from its previous closing price. On the day, 4.64 million shares were traded. INSP stock price reached its highest trading level at $186.4 during the session, while it also had its lowest trading level at $156.83.
Ratios:
Our goal is to gain a better understanding of INSP by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1504.96. For the most recent quarter (mrq), Quick Ratio is recorded 7.25 and its Current Ratio is at 7.93. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on May-09-24, Downgraded its rating to Neutral and sets its target price to $225 from $265 previously.
On April 19, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $285.
On March 19, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $250.Morgan Stanley initiated its Overweight rating on March 19, 2024, with a $250 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 17 ’24 when Buchholz Richard sold 15,000 shares for $230.03 per share. The transaction valued at 3,450,450 led to the insider holds 28,271 shares of the business.
Herbert Timothy P. sold 40,000 shares of INSP for $8,203,581 on Apr 01 ’24. The CEO and President now owns 63,658 shares after completing the transaction at $205.09 per share. On Apr 01 ’24, another insider, Griffin Jerry C, who serves as the Director of the company, sold 32 shares for $213.99 each. As a result, the insider received 6,848 and left with 10,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 4950881792 and an Enterprise Value of 6872478208. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.49 while its Price-to-Book (P/B) ratio in mrq is 8.23. Its current Enterprise Value per Revenue stands at 10.398 whereas that against EBITDA is -208.09.
Stock Price History:
The Beta on a monthly basis for INSP is 1.42, which has changed by -0.14782822 over the last 52 weeks, in comparison to a change of 0.2537824 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $330.00, while it has fallen to a 52-week low of $123.27. The 50-Day Moving Average of the stock is -24.12%, while the 200-Day Moving Average is calculated to be -18.08%.
Shares Statistics:
The stock has traded on average 481.58K shares per day over the past 3-months and 416900 shares per day over the last 10 days, according to various share statistics. A total of 30.30M shares are outstanding, with a floating share count of 29.66M. Insiders hold about 2.10% of the company’s shares, while institutions hold 103.93% stake in the company. Shares short for INSP as of 1713139200 were 2312464 with a Short Ratio of 4.80, compared to 1710460800 on 1867485. Therefore, it implies a Short% of Shares Outstanding of 2312464 and a Short% of Float of 8.75.
Earnings Estimates
Inspire Medical Systems Inc (INSP) is currently under the scrutiny of 17.0 analysts, each contributing to the ongoing evaluation of its stock.On average, analysts expect EPS of -$0.23 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.5, while EPS last year was -$0.41. The consensus estimate for the next quarter is -$0.07, with high estimates of $0.18 and low estimates of -$0.32.
Analysts are recommending an EPS of between $0.21 and -$1.17 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is $0.62, with 18.0 analysts recommending between $2.41 and -$0.33.
Revenue Estimates
For the next quarter, 17 analysts are estimating revenue of $196.49M. There is a high estimate of $203.4M for the next quarter, whereas the lowest estimate is $190.5M.
A total of 18 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $796.1M, while the lowest revenue estimate was $775M, resulting in an average revenue estimate of $782.26M. In the same quarter a year ago, actual revenue was $624.8MBased on 18 analysts’ estimates, the company’s revenue will be $950.97M in the next fiscal year. The high estimate is $996.85M and the low estimate is $899.59M.
